Literature DB >> 34012216

Transcatheter Device Closure of Secundum Atrial Septal Defect in Adult Patient.

Nabil Naser1, Nura Hadziomerovic1, Sevleta Avdic2.   

Abstract

BACKGROUND: Atrial septal abnormalities are common congenital lesions remaining asymptomatic until adulthood in a great number of patients. The most frequent atrial septal defects in adults are ostium secundum atrial septal defect (ASD). Complications from untreated, hemodynamically significant ASD are atrial arrhythmia, paradoxical embolization, Eisenmenger's syndrome, pulmonary hypertension, and right ventricular failure.
OBJECTIVE: We present a case report of secundum ASD in adult female patient who underwent transcatheter device closure with Amplatzer occluder. METHODS AND
RESULTS: The case of female Bosnian patient 50 years old who lives in Belgium for 20 years ago and during her visit to Bosnia she came to our polyclinic for cardiological exam. Echocardiographic exam showed enlargement of left atrium (LAD 51mm), right atrium and ventricle (RAD 46mm, RVd 33mm), atrial septal defect 9mm with left right shunt Qp:Qs 2,3:1. Several months later transcatheter device closure with Amplatzer occluder was performed and subsequent symptomatic improvement reported after closure.
CONCLUSION: Echocardiography has superior role for precise evaluation of ASD type secundum who are suitable for transcatheter device closure as primary treatment option. Transcatheter techniques has now become preferable to surgical repair and provide valid option of treatment for this type of CHD.
© 2021 Nabil Naser, Nura Hadziomerovic, Sevleta Avdic.

Entities:  

Keywords:  Amplatzer occluder; Atrial septal defect (ASD); Doppler echocardiography; atrial septal occluder (ASO); echocardiography; transcatheter device closure

Year:  2021        PMID: 34012216      PMCID: PMC8116089          DOI: 10.5455/aim.2021.29.65-70

Source DB:  PubMed          Journal:  Acta Inform Med        ISSN: 0353-8109


BACKGROUND

Atrial septal defect (ASD) is the most common type of congenital heart disease (CHD) in adults which cause shunting of blood between the systemic and pulmonary circulations (1, 2). The estimated birth prevalence of 1.6 per 1000 live births and a 97% probability of survival into adulthood. During the last decade, there has been remarkable change in the treatment strategy of ASD, shifting the therapeutic gold standard from surgery to transcatheter closure, along with refinements and the evolution of device technology.

OBJECTIVE

We present a case report of secundum ASD in adult patient. Echocardiography as non-invasive imaging method and Transesophageal echocardiography has superior role for precise evaluation of ASD type secundum who are suitable for device closure with Amplatzer septal occluder as primary treatment option.

CASE REPORT

We present a case of female Bosnian patient 50 years old who lives in Belgium for 20 years ago and during her visit to Bosnia she came to our polyclinic for cardiological exam. In the last 4 years ago, she complained of cardiac arrhythmia, palpitations, anaemia and iron deficiency and high blood pressure. During physical exam she was acyanotic, BP 150/100 mmHg, HR 83/min, Spo2 96%, respiratory rate 15 breaths/min. and BMI 30. The cardiovascular examinations revealed regular heartbeat with rumbling middiastolic murmur at the lower left sternal border. ECG showed sinus rhythm, RBBB with rSR1 in V1 lead. Transthoracic echocardiographic showed enlargement of left atrium (LAD 51mm), right atrium and ventricle (RAD 46mm, RVd 33mm), atrial septal defect with left right shunt and mild mitral regurgitation, mild pulmonary hypertension and Qp:Qs 2,3:1. Blood lab analysis showed anaemia with low Hb 91 g/L, low HcT 28%, low Iron 8 μmol/L and high lipids. Next day the 2D and 3D Transesophageal (TEE) exam confirmed the existence of secundum atrial septal defect 9mm diameter size with left right shunt and mild mitral regurgitation, no signs of pulmonary hypertension. Several months later transcatheter device closure with Amplatzer occluder was performed and subsequent symptomatic improvement reported after closure (Panels A, B, C, D).

RESULTS AND DISCUSSION

ASD is one of the most common congenital heart lesions in adults that requires intervention. Many patients with ASDs are free of overt symptoms, although most will become symptomatic at some point in their lives (3, 4). Exercise intolerance in the form of exertional dyspnoea or fatigue is the most common initial presenting symptom (1, 2). Complications from untreated, hemodynamically significant ASD atrial arrhythmia, paradoxical embolization, Eisenmenger’s syndrome, pulmonary hypertension, and right ventricular failure. The mortality rate from untreated, hemodynamically significant ASD can approach 25% (3, 5, 6). Transesophageal echocardiography is powerful method to confirm the type of ASD and to delineate the pulmonary venous return. TEE can show unique views of the entire anatomy of ASD and facilitates monitoring of transcatheter procedures for deployment of an Amplatzer septal occluder (7, 8, 9). Patients with isolated atrial septal defects have benefited from important recent advances in the diagnosis, evaluation, and management of this congenital lesion (7, 10). Current guidelines recommend that all patients with hemodynamically significant ASD should undergo ASD closure, regardless of symptoms, to prevent long-term complications such as atrial arrhythmias, pulmonary hypertension, and/or paradoxical embolism (6). The atrial septal occluder (ASO) was approved for transcatheter closure of secundum ASD in the United States in 2001 (13). Trans-catheter closure of secundum ASD with a self-expanding Amplatzer septal occluder has become an alternative to surgical closure (7, 8, 9). Acute complications are rare but may include tears of the atrial septum from the sizing balloon, device embolization or entrapment, stroke, and cardiac tamponade (4, 10). The transcatheter closure of the ASD has low incidence of morbidity and mortality, and an important advantage of the ASO is that it can be easily retrieved into the delivery sheath and re-deployed several times before final release. This greatly diminishes the risk of the malposition and embolization of the device (14). Transcatheter closure is much less invasive than surgery, also has fewer periprocedural complications, and is associated with a shorter length of stay. Approximately 80% of secundum ASD are suitable for closure using currently available devices (6-14). Transcatheter closure of secundum ASD has been shown to be safe and effective in patients with right heart volume overload, with similar success and complication rates compared with surgery (5, 13, 14, 15).

CONCLUSION

Atrial septal defect secundum is the most common CHD. It constitutes about 80% of these defects, has a female predominance of approximately 2:1, and is frequently discovered in adulthood. Patients with an isolated ASD secundum often remain asymptomatic during childhood and adolescence, the rates of exercise intolerance, supraventricular arrhythmias, right ventricular dysfunction, and pulmonary arterial hypertension increase with patient age, enlargement of the right heart chambers in ASD are subject to important age-related morbidity and reduced life-expectancy. Echocardiography as non-invasive imaging method and Transesophageal echocardiography (2 and 3D) remains valuable non-invasive diagnostic method for locating and assessing ASD. All hemodynamically significant secundum ASDs should be closed, regardless of age and symptoms. Transcatheter techniques has now become preferable to surgical repair and provide valid option of treatment for this type of CHD.
  21 in total

1.  Surgical versus percutaneous occlusion of ostium secundum atrial septal defects: results and cost-effective considerations in a low-income country.

Authors:  Vladimiro L Vida; Joaquin Barnoya; Mauricio O'Connell; Juan Leon-Wyss; Luis A Larrazabal; Aldo R Castañeda
Journal:  J Am Coll Cardiol       Date:  2006-01-17       Impact factor: 24.094

Review 2.  Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence.

Authors:  Gianfranco Butera; Giuseppe Biondi-Zoccai; Giuseppe Sangiorgi; Raul Abella; Alessandro Giamberti; Claudio Bussadori; Imad Sheiban; Zackhia Saliba; Tiberio Santoro; Gabriele Pelissero; Mario Carminati; Alessandro Frigiola
Journal:  EuroIntervention       Date:  2011-07       Impact factor: 6.534

3.  2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Karen K Stout; Curt J Daniels; Jamil A Aboulhosn; Biykem Bozkurt; Craig S Broberg; Jack M Colman; Stephen R Crumb; Joseph A Dearani; Stephanie Fuller; Michelle Gurvitz; Paul Khairy; Michael J Landzberg; Arwa Saidi; Anne Marie Valente; George F Van Hare
Journal:  J Am Coll Cardiol       Date:  2018-08-16       Impact factor: 24.094

4.  Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry.

Authors:  M G J Duffels; P M Engelfriet; R M F Berger; R L E van Loon; E Hoendermis; J W J Vriend; E T van der Velde; P Bresser; B J M Mulder
Journal:  Int J Cardiol       Date:  2006-12-19       Impact factor: 4.164

5.  The role of transesophageal echocardiography in transcatheter closure of secundum atrial septal defects by the Amplatzer septal occluder.

Authors:  U Mazic; P Gavora; J Masura
Journal:  Am Heart J       Date:  2001-09       Impact factor: 4.749

6.  Effect on right ventricular volume of percutaneous Amplatzer closure of atrial septal defect in adults.

Authors:  Jeffrey M Schussler; Azam Anwar; Sabrina D Phillips; Brad J Roberts; Ravi C Vallabhan; Paul A Grayburn
Journal:  Am J Cardiol       Date:  2005-04-15       Impact factor: 2.778

7.  Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication.

Authors:  Gerhard-Paul Diller; Konstantinos Dimopoulos; Darlington Okonko; Wei Li; Sonya V Babu-Narayan; Craig S Broberg; Bengt Johansson; Beatriz Bouzas; Michael J Mullen; Philip A Poole-Wilson; Darrel P Francis; Michael A Gatzoulis
Journal:  Circulation       Date:  2005-08-01       Impact factor: 29.690

8.  The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: An Analysis of the IMPACT Registry®.

Authors:  Michael L O'Byrne; Matthew J Gillespie; Kevin F Kennedy; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Catheter Cardiovasc Interv       Date:  2016-05-18       Impact factor: 2.692

9.  Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study.

Authors:  Daniel R Turner; Carl Y Owada; Charlie J Sang; Muhammad Khan; D Scott Lim
Journal:  Circ Cardiovasc Interv       Date:  2017-08       Impact factor: 6.546

10.  Transcatheter closure of atrial septal defect with amplatzer septal occluder in adults: immediate, short, and intermediate-term results.

Authors:  Mostafa Behjati; Mansour Rafiei; Mohammad Hossein Soltani; Mahmoud Emami; Majid Dehghani
Journal:  J Tehran Heart Cent       Date:  2011-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.